Explaining variability in ciclosporin exposure in adult kidney transplant recipients

PURPOSE: Optimal ciclosporin A (CsA) exposure in kidney transplant recipients is difficult to attain because of variability in CsA pharmacokinetics. A better understanding of the variability in CsA exposure could be a good means of individualizing therapy. Specifically, genetic variability in genes...

Descripción completa

Detalles Bibliográficos
Autores principales: Press, Rogier R., Ploeger, Bart A., den Hartigh, Jan, van der Straaten, T., van Pelt, Hans, Danhof, Meindert, de Fijter, Hans, Guchelaar, Henk-Jan
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Pharmacogenetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868991/
https://www.ncbi.nlm.nih.gov/pubmed/20354687
http://dx.doi.org/10.1007/s00228-010-0810-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2868991/
https://www.ncbi.nlm.nih.gov/pubmed/20354687
http://dx.doi.org/10.1007/s00228-010-0810-9

Ejemplares similares